[go: up one dir, main page]

AR100365A1 - Composición acuosa que comprende ibuprofeno y paracetamol en combinación, proceso para fabricarla y dispositivo inyector para administrarla - Google Patents

Composición acuosa que comprende ibuprofeno y paracetamol en combinación, proceso para fabricarla y dispositivo inyector para administrarla

Info

Publication number
AR100365A1
AR100365A1 ARP150101427A ARP150101427A AR100365A1 AR 100365 A1 AR100365 A1 AR 100365A1 AR P150101427 A ARP150101427 A AR P150101427A AR P150101427 A ARP150101427 A AR P150101427A AR 100365 A1 AR100365 A1 AR 100365A1
Authority
AR
Argentina
Prior art keywords
paracetamol
combination
administrate
manufacture
composition including
Prior art date
Application number
ARP150101427A
Other languages
English (en)
Inventor
Jacobsen Thomas
Original Assignee
Everbright Pharmaceuticals S A R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Everbright Pharmaceuticals S A R L filed Critical Everbright Pharmaceuticals S A R L
Publication of AR100365A1 publication Critical patent/AR100365A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093—Containers having several compartments for products to be mixed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/1407—Infusion of two or more substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/19—Syringes having more than one chamber, e.g. including a manifold coupling two parallelly aligned syringes through separate channels to a common discharge assembly
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)

Abstract

Reivindicación 1: Una composición acuosa que comprende ibuprofeno y paracetamol en combinación, caracterizada por comprender de 2,8 a 3,2 mg de ibuprofeno y de 9,8 a 10,2 mg de paracetamol, expresados por ml de dicha composición, siendo el pH de dicha composición de 6,3 a 7,3.
ARP150101427A 2014-07-18 2015-05-11 Composición acuosa que comprende ibuprofeno y paracetamol en combinación, proceso para fabricarla y dispositivo inyector para administrarla AR100365A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2014/065544 WO2016008546A1 (en) 2014-07-18 2014-07-18 Aqueous formulation comprising paracetamol and ibuprofen

Publications (1)

Publication Number Publication Date
AR100365A1 true AR100365A1 (es) 2016-09-28

Family

ID=51211244

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150101427A AR100365A1 (es) 2014-07-18 2015-05-11 Composición acuosa que comprende ibuprofeno y paracetamol en combinación, proceso para fabricarla y dispositivo inyector para administrarla

Country Status (26)

Country Link
US (4) US11219609B2 (es)
EP (2) EP3656377B1 (es)
JP (2) JP6745798B2 (es)
CN (2) CN106794163B (es)
AR (1) AR100365A1 (es)
AU (1) AU2015289035B2 (es)
BR (1) BR112017001093B1 (es)
CA (1) CA2955557C (es)
CY (1) CY1122899T1 (es)
DK (1) DK3169307T3 (es)
EA (1) EA036212B1 (es)
ES (1) ES2791349T3 (es)
HR (1) HRP20200704T1 (es)
HU (1) HUE048881T2 (es)
IL (1) IL250112B2 (es)
LT (1) LT3169307T (es)
MX (1) MX2017000764A (es)
MY (1) MY192813A (es)
NZ (1) NZ728796A (es)
PL (1) PL3169307T3 (es)
PT (1) PT3169307T (es)
RS (1) RS60289B1 (es)
SG (1) SG11201700421RA (es)
SI (1) SI3169307T1 (es)
TN (1) TN2017000011A1 (es)
WO (2) WO2016008546A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016008546A1 (en) * 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
US11541024B2 (en) * 2016-08-02 2023-01-03 Ambah Ip Limited Stable ibuprofen injectable composition
DE102017202510A1 (de) 2017-02-16 2018-08-16 Eurozyto Gmbh Behältnis zur Bereitstellung patientenspezifischer Arzneimittel
WO2018192664A1 (en) 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF
WO2022178018A1 (en) * 2021-02-19 2022-08-25 Nevakar Injectables Inc. Liquid unit dosage forms for treatment of pain
CN114062554B (zh) * 2021-11-20 2023-07-21 山东百诺医药股份有限公司 一种同时测定对乙酰氨基酚布洛芬有关物质的分析方法
WO2024246565A2 (en) 2023-06-02 2024-12-05 Ioulia Tseti Pharmaceutical composition comprising ibuprofen
GR1010809B (el) * 2023-09-13 2024-10-25 Ιουλια Τσετη Υδατικο διαλυμα ιβουπροφαινης παρακεταμολης για χρηση σε ενδοφλεβια χορηγηση
GR1010769B (el) * 2023-07-27 2024-09-18 Ιουλια Κλεωνος Τσετη Υδατικο διαλυμα ιβουπροφαινης για χρηση σε ενδοφλεβια χορηγηση

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2809619B1 (fr) * 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
US20060100578A1 (en) 2004-09-13 2006-05-11 Tandem Medical, Inc. Medication delivery apparatus and methods for intravenous infusions
KR20110065417A (ko) 2008-01-03 2011-06-15 욱크하르트 리미티드 파라세타몰 및 이부프로펜을 포함하는 경구 약제학적 현탁액
TR201102810T2 (tr) 2008-10-14 2011-05-23 Aft Pharmaceuticals Limited Tıbbi bir ürün ve tedavi
EP2243477A1 (de) * 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol zur parenteralen Verabreichung
US8404748B2 (en) * 2009-08-13 2013-03-26 Neogen N.V. Storage-stable formulation of paracetamol in aqueous solution
PL2389923T3 (pl) * 2010-05-19 2013-06-28 Uni Pharma Kleon Tsetis Pharmaceutical Laboratories S A Trwały, gotowy do użycia iniekcyjny preparat paracetamolu
CN107519159A (zh) * 2010-11-04 2017-12-29 阿福特药物有限公司 复方组合物
BE1020614A5 (nl) * 2012-01-27 2014-01-07 Hubert De Backer Nv Injectiespuit.
US9072661B2 (en) * 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
ES2647843T3 (es) * 2012-03-16 2017-12-26 Cumberland Pharmaceuticals Inc. Formulación inyectable de ibuprofeno
WO2016008546A1 (en) * 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
WO2018192664A1 (en) 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF

Also Published As

Publication number Publication date
AU2015289035B2 (en) 2020-03-26
PT3169307T (pt) 2020-05-18
US20230181502A1 (en) 2023-06-15
SI3169307T1 (sl) 2020-07-31
CN106794163A (zh) 2017-05-31
EA036212B1 (ru) 2020-10-14
WO2016009067A1 (en) 2016-01-21
US20170209398A1 (en) 2017-07-27
BR112017001093B1 (pt) 2023-01-31
HUE048881T2 (hu) 2020-08-28
US12083087B2 (en) 2024-09-10
IL250112A0 (en) 2017-03-30
PL3169307T3 (pl) 2020-09-21
HRP20200704T1 (hr) 2020-07-24
EP3656377B1 (en) 2025-02-12
EP3169307A1 (en) 2017-05-24
RS60289B1 (sr) 2020-07-31
JP2017522382A (ja) 2017-08-10
LT3169307T (lt) 2020-07-10
AU2015289035A1 (en) 2017-02-23
CA2955557C (en) 2021-06-22
CY1122899T1 (el) 2021-05-05
US11389416B2 (en) 2022-07-19
JP6892494B2 (ja) 2021-06-23
MY192813A (en) 2022-09-09
EP3169307B1 (en) 2020-02-19
EA201790223A1 (ru) 2017-05-31
MX2017000764A (es) 2017-08-18
DK3169307T3 (da) 2020-05-11
JP2020059740A (ja) 2020-04-16
BR112017001093A2 (pt) 2017-11-14
US20190343785A1 (en) 2019-11-14
US11219609B2 (en) 2022-01-11
CN113018258A (zh) 2021-06-25
US20220031645A1 (en) 2022-02-03
CA2955557A1 (en) 2016-01-21
IL250112B (en) 2022-10-01
SG11201700421RA (en) 2017-02-27
TN2017000011A1 (en) 2018-07-04
CN106794163B (zh) 2021-03-26
JP6745798B2 (ja) 2020-08-26
IL250112B2 (en) 2023-02-01
WO2016008546A1 (en) 2016-01-21
US11213498B2 (en) 2022-01-04
ES2791349T3 (es) 2020-11-04
EP3656377A1 (en) 2020-05-27
NZ728796A (en) 2023-05-26

Similar Documents

Publication Publication Date Title
AR100365A1 (es) Composición acuosa que comprende ibuprofeno y paracetamol en combinación, proceso para fabricarla y dispositivo inyector para administrarla
PH12016501236A1 (en) Stable and palatable liquid pharmaceutical composition of phenylephrine and a maleate salt of an antihistamine
TN2017000246A1 (en) Anti-c10orf54 antibodies and uses thereof
BR112018075140A2 (pt) composição na forma de uma solução aquosa injetável, e, formulação de dose única a um ph de 7 a 7,8
CL2016002169A1 (es) Inhibidores de diacilglicerol aciltransferasa 2 para uso en el tratamiento de trastornos metabólicos y relacionados.
GT201500053A (es) Composicion farmaceutica recubierta que contiene regorafenib
CY1122264T1 (el) Ppar ενωσεις για χρηση στην αντιμετωπιση των ινωτικων νοσων
CO2017005500A2 (es) Método para la producción de un sistema de administración farmacéutica
CL2016001756A1 (es) Preparación farmacéutica que comprende 0,001-0,003 pv de 6-4-pirazol-1-ilbencilpiridin-3-ilsulfonilaminometilpiridin-2-ilaminoacetato de isopropilo o una sal del mismo uso para el tratamiento o prevención de glaucoma o hipertensión ocular.
CO2017000446A2 (es) Proceso para la preparacion de ácidos 4–alcoxi –3– hidroxipicolínicos
CO2018003224A2 (es) Formulaciones de aminoacidos de liberacion modificada administradas oralmente
AR102563A1 (es) Composición densificada para el tratamiento de una formación subterránea
CL2016003074A1 (es) Compuestos derivados de 2-oxi-2-fenil-n-5-pirrolidin-3-ilamino-1,3,4-tiadiazol-2-ilacetamida, inhibidores gls1 composición farmacéutica y su uso para tratar el cáncer.
EA201690036A1 (ru) Состав с отсроченным высвобождением, содержащий гранулы цистеамина, и способы его получения и применения
BR112017000730B8 (pt) Derivados de pirrolidinona como inibidores de metap-2, e medicamentos
PH12016502530A1 (en) Pharmaceutical compositions comprising dgla and use of same
UY36173A (es) Metodo de tratamiento de enfermedades relacionadas con el factor inducible por hipoxia
CL2016001094A1 (es) Silicato de zirconio microporoso para el tratamiento de hipercalemia.
CO2017000010A2 (es) Proceso para la preparacion de ácidos 3-hidroxipicolínicos
BR112015016033A8 (pt) composições farmacêuticas para tratamento de infecções por bactérias, e seus usos
PE20140811A1 (es) Precipitacion de zinc de la solucion
CR20160369A (es) Composiciones para uso en el tratamiento de afecciones alérgicas
CL2017001383A1 (es) Proceso para la fabricación de anhídrido carboxílico
MX2017007596A (es) Procedimiento para fabricar partículas de resinato de fenilefrina; partículas de resinato de fenilefrina; y uso de las partículas de resinato de fenilefrina en formulaciones farmacéuticas.
PH12016501245A1 (en) Stable and palatable liquid pharmaceutical composition of phenylephrine and a maleate salt of an antihistamine

Legal Events

Date Code Title Description
FC Refusal